Etoposide Injection
Product Images NDC 0143-9376

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Etoposide (NDC 0143-9376). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Etoposide Injection Usp Novaplus 1)

Chemical structure of Etoposide, an active ingredient in the injection formulation labeled by Hikma Pharmaceuticals USA Inc. This molecular diagram displays the arrangement of atoms and bonds characteristic of Etoposide.*

FDA Label Image

Etoposide Injection, Usp 100 mg/5 mL Label (Etoposide Injection Usp Novaplus 2)

Label for Etoposide Injection, USP 100 mg/5 mL (20 mg/mL) intravenous injection by Hikma Pharmaceuticals USA Inc. It is a 5 mL multiple-dose vial requiring dilution before administration. The label includes dosage information, storage instructions, and active ingredient details.*

FDA Label Image

Representative Serialization Image (Etoposide Injection Usp Novaplus 3)

Label from Etoposide injection, 20 mg/mL by Hikma Pharmaceuticals USA Inc. The label shows a QR code and text fields for GTIN, serial number, expiration date, and lot number for product identification and traceability.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.